欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号IE/H/0740/001
药品名称Gaviscon Strawberry Flavour Chewable Tablets
活性成分
    • Sodium alginate 160.0 mg
剂型Chewable tablet
上市许可持有人Reckitt Benckiser Healthcare (UK) Limited Danson Lane, Hull HU8 7DS, East Yorkshire, UK
参考成员国 - 产品名称Ireland (IE)
互认成员国 - 产品名称
    • Cyprus (CY)
      GAVISCON STRAWBERRY chewable TABS
    • Belgium (BE)
    • Romania (RO)
      Gaviscon cu aromă de căpşuni comprimate masticabile
    • Greece (EL)
      GAVISCON® STRAWBERRY TABLETS
    • Germany (DE)
    • Bulgaria (BG)
      Gaviscon Strawberry
    • Austria (AT)
    • Portugal (PT)
    • Luxembourg (LU)
    • Netherlands (NL)
许可日期2008/04/05
最近更新日期2025/11/05
药物ATC编码
    • A02BX13 alginic acid
申请类型
  • TypeLevel1:
  • TypeLevel2:
  • TypeLevel3:
  • TypeLevel4:
  • TypeLevel5:
附件文件下载
    市场状态Positive
    ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase